Telemonitoring During Phase 2-3 Cardiac Rehabilitation
TeleRehabII
Impact of Telemonitoring Intervention on Physical Activity, CVD Risk Factors, During Phase 2-3 Cardiac Rehabilitation
1 other identifier
interventional
80
1 country
1
Brief Summary
In this study, 80 coronary artery disease patients with successful coronary revascularisation (by CABG or PCI) will be included. Patients are excluded in case of: congestive heart failure, ICD or pacemaker, any disability limiting exercise participation. These patients are attending phase 2-3 cardiac rehabilitation, and have completed 6 weeks of rehabilitation. Next, subjects are randomly assigned to a control group or an intervention group. Outcome parameters: physical activity, exercise capacity, blood glucose, insulin level and lipid profile, body weight and waist circumference, cardiovascular morbidity and mortality. Hypothesis: telemonitoring of physical activity will increase physical activity, and improve cardiovascular disease risk factors, in CAD patients attending phase 2-3 cardiac rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Jan 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 1, 2010
CompletedFirst Posted
Study publicly available on registry
December 2, 2010
CompletedStudy Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedAugust 17, 2016
August 1, 2016
1.9 years
December 1, 2010
August 15, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Physical activity
every week
Secondary Outcomes (3)
exercise capacity
every 6 weeks
blood lipid profile, glucose and insulin level
every 6 weeks
mortality and morbidity
continuously
Study Arms (2)
intervention
EXPERIMENTALstimulation of physical activity by messages sent through e mail or SMS; in combination with monitoring of physical activity with physical activity monitors
control
PLACEBO COMPARATORno stimulation of physical activity
Interventions
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jessa Hospitallead
Study Sites (1)
Jessa Hospital
Hasselt, 3500, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul A Dendale, MD, PhD
University of Hasselt, Hasselt, Belgium
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- dr
Study Record Dates
First Submitted
December 1, 2010
First Posted
December 2, 2010
Study Start
January 1, 2011
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
August 17, 2016
Record last verified: 2016-08